PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsTerlipressinum
Terlipressinum
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
105 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver cirrhosisD008103EFO_0001422K74.018551631
HemorrhageD006470MP_0001914R58—2291427
FibrosisD005355——17551125
Hepatorenal syndromeD006530—K76.71593924
SyndromeD013577——1573619
Septic shockD012772—A48.31761618
ShockD012769—R57.1—751515
Acute kidney injuryD058186HP_0001919N17—213713
Esophageal and gastric varicesD004932EFO_0009545I85——14712
Portal hypertensionD006975EFO_0000666K76.6—1—359
Show 10 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AscitesD001201HP_0001541R18143—29
Liver failureD017093HP_0001399K72.9—11—79
Hepatic insufficiencyD048550————1—67
Drug-related side effects and adverse reactionsD064420—T88.7—22——4
HypotensionD007022EFO_0005251I95——1—23
SepsisD018805HP_0100806A41.9—12——2
HemoptysisD006469HP_0002105R04.2——1—12
Retinal diseasesD012164HP_0000479H35.9—11——1
Premature birthD047928EFO_0003917O60—11——1
Retinopathy of prematurityD012178EFO_1001158H35.1—11——1
Show 5 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Neonatal sepsisD000071074HP_0040187——1———1
Renal insufficiencyD051437HP_0000083N19—1———1
Liver neoplasmsD008113EFO_1001513C22.0—1———1
Portal pressureD017082———1———1
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
End stage liver diseaseD058625EFO_1001311K72.1————77
Acute-on-chronic liver failureD065290——————77
Liver diseasesD008107HP_0002910K70-K77————22
Surgical portasystemic shuntD011170——————22
Varicose veinsD014648HP_0002619I83.90————11
Acute diseaseD000208——————11
Uterine myomectomyD063186——————11
ThrombosisD013927——————11
Venous thrombosisD020246HP_0004936I82.40————11
Chronic renal insufficiencyD051436—N18————11
Show 2 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use